Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 USD | +7.47% | -0.43% | -64.04% |
Apr. 18 | Sector Update: Health Care Stocks Ease in Afternoon Trading | MT |
Apr. 18 | Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU | MT |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 15-07-27 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 16-08-21 |
Chief Tech/Sci/R&D Officer | 71 | - | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 17-11-07 |
Dennis McNamara
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Michael Cannon
BRD | Director/Board Member | 78 | 15-06-30 |
John Climaco
BRD | Director/Board Member | 55 | 17-07-23 |
Elizabeth Cermak
BRD | Director/Board Member | 66 | 20-10-01 |
Robert George
BRD | Director/Board Member | 74 | 15-06-30 |
Joy Yan
BRD | Director/Board Member | 44 | 22-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,227,513 | 2,123,974 ( 95.35 %) | 0 | 95.35 % |
Company contact information
Moleculin Biotech, Inc.
5300 Memorial Drive Suite 950
77007, Houston
+(713) 300-5160
http://www.moleculin.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.04% | 9.6M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- MBRX Stock
- Company Moleculin Biotech, Inc.